Skip to main content
Cyprus banner
🇨🇾

Cyprus

20% CGT on Cyprus property gains; non-dom exempts dividends/interest (SDC), not property CGT; SDC on rental income abolished from 2026; PRP from €300K

🟢

Currency Risk

EUR

Golden Visa ✅DTA with China156,026 monitored sale listings
Investor Profile:
Currency:
Gross Yield3.5%–7.5%
Entry PriceFrom €2,195 (¥17,009)/m² · Nicosia
Purchase Tax3%
CGT Rate20%
Golden Visa
Non-Res Mortgage
China DTA

* Exchange rates shown for illustration only, based on ECB mid-market rate. Actual transactions may be subject to conversion fees.

TIER 2 — CONDITIONAL BUYMacro: 22/30
🇮🇱Israeli70.0/100
🇩🇪German68.1/100
🇫🇷French63.5/100
🇳🇱Dutch63.6/100
🇧🇪Belgian72.6/100
🇬🇧UK70.0/100
🇺🇸US69.6/100
🇨🇦Canadian66.7/100
🇮🇳Indian70.0/100
🇨🇳Chinese70.0/100
🇪🇺Other EU70.0/100

Strengths

  • English common law; EU member; 12.5% corporate tax
  • Limassol: proven expat demand and rental growth
  • PRP residency from €300K — fastest EU residency program

Risks

  • Russian demand cooling significantly 2024–2025
  • Buffer zone law 2025: non-EU nationals banned from properties near UN line
  • Northern Cyprus: ECHR-validated restitution risks — avoid

CASABROVA Verdict

Suitable for Israeli and British investors familiar with the English common law framework.

Chinese: CASABROVA Score 70.0 (rank #13) for this profile.

Recommended Strategy

Limassol or Paphos. New builds only. Avoid buffer zone. English-law conveyancer mandatory.

Based on CASABROVA Waves 1–8, Q1 2026. Not financial or legal advice.

⚠️

Important Legal Disclaimer

The information presented on CASABROVA is for general informational purposes only and does not constitute legal, financial, tax, or investment advice. This information is not binding and should not be relied upon as the basis for any decision. Before executing any transaction or investment in overseas real estate, consult with a qualified lawyer, accountant, tax advisor, and/or any other relevant professional in the relevant territory.

Tax, regulatory, and yield data change frequently. CASABROVA makes efforts to update information weekly from primary sources, but is not responsible for the accuracy of the information or for changes not yet reflected. All figures presented are indicative only.